Why the study?
Does oral anticoagulation reduce stroke and mortality in patients with atrial fibrillation?
Population
Patients with atrial fibrillation
Comparison
Oral anticoagulation, including direct oral… vs No anticoagulation, or DOACs compared to VKAs
Design
Review
Authors
Loading...
Supports OAC initiation above 1-2% stroke risk in AF; reinforces RCT-derived net-benefit thresholds for practice.
Does oral anticoagulation reduce stroke and mortality in patients with atrial fibrillation?
This narrative review reinforces that oral anticoagulation is the cornerstone of thromboembolism prevention in atrial fibrillation, highlighting the preference for DOACs over VKAs in most patients.
Johner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: